Referências

1. Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr, 2008.
2. O’Sullivan SE. An update on PPAR activation by cannabinoids. Br J Pharmacol, 2016.
3. Atalay S et al. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants, 2019.
4. Esposito G et al. Cannabidiol in inflammatory conditions: influence on PPAR-γ. Neuropharmacology, 2011.
5. Oláh A et al. Cannabidiol exerts sebostatic and anti-inflammatory effects on human sebocytes. J Clin Invest, 2014.
6. Pisanti S et al. Cannabidiol: state of the art and new challenges for therapeutic applications. Pharmacol Ther, 2017.